Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 731, February 1, 2009. Published Online First January 20, 2009;
doi: 10.1158/0008-5472.CAN-08-3349
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-08-3349v1
69/3/731    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chinnadurai, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinnadurai, G.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Identification, Validation, and Markers

Reviews

The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors

G. Chinnadurai

Institute for Molecular Virology, Saint Louis University Health Sciences Center, Doisy Research Center, St. Louis, Missouri

Requests for reprints: G. Chinnadurai, Institute for Molecular Virology, Saint Louis University Health Sciences Center, Doisy Research Center, 1100 South Grand Boulevard, St. Louis, MO 63104. Phone: 314-977-8794; Fax: 314-977-8798; E-mail: chinnag{at}slu.edu.

Key Words: CtBP • EMT • tumor suppressors

CtBP1 and CtBP2 are closely related and evolutionarily conserved transcriptional corepressors. There is strong evidence linking CtBPs to tumorigenesis and tumor progression. CtBPs promote epithelial-mesenchymal transition and function as apoptosis antagonists. Also, CtBPs mediate repression of several tumor suppressor genes. Certain tumor suppressors also target CtBPs to restrain their tumor-promoting activity. Down-regulation of CtBPs mediated by some tumor suppressors results in p53-independent apoptosis and reduced tumor cell migration and invasion. The role of CtBPs in modulating the activities of different tumor suppressors is reviewed here. The results discussed here suggest that CtBPs may constitute a novel p53-independent anticancer target. [Cancer Res 2009;69(3):731–4]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Palijan, I. Fernandes, M. Verway, M. Kourelis, Y. Bastien, L. E. Tavera-Mendoza, A. Sacheli, V. Bourdeau, S. Mader, and J. H. White
Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression
J. Biol. Chem., October 30, 2009; 284(44): 30275 - 30287.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. M. Bergman, C. N. Birts, M. Darley, B. Gabrielli, and J. P. Blaydes
CtBPs Promote Cell Survival through the Maintenance of Mitotic Fidelity
Mol. Cell. Biol., August 15, 2009; 29(16): 4539 - 4551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.